CNS Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNSP and other ETFs, options, and stocks.

About CNSP

CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12.

CEO

John M. Climaco

CEOJohn M. Climaco

Employees

Employees5

Headquarters

Houston, Texas

HeadquartersHouston, Texas

Founded

2017

Founded2017

Employees

Employees5

CNSP Key Statistics

Market cap

2.75M

Market cap2.75M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

203.72K

Average volume203.72K

High today

$0.9599

High today$0.9599

Low today

$0.83

Low today$0.83

Open price

$0.899

Open price$0.899

Volume

101.11K

Volume101.11K

52 Week high

$800.00

52 Week high$800.00

52 Week low

$0.7715

52 Week low$0.7715

CNS Pharmaceuticals

Why Robinhood?

CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. Show more

CNSP Key Statistics

CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12.